Stem cell technology in breast cancer: current status and potential applications

References

• LapidotTSirardCVormoorJA cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature199436764646456487509044
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A200310073983398812629218
   PubMed Web of Science ®Google Scholar
• SinghSKHawkinsCClarkeIDIdentification of human brain tumour initiating cellsNature2004432701539640115549107
   PubMed Web of Science ®Google Scholar
• YangZFNgaiPHoDWIdentification of local and circulating cancer stem cells in human liver cancerHepatology200847391992818275073
   PubMed Web of Science ®Google Scholar
• DalerbaPDyllaSJParkIKPhenotypic characterization of human colorectal cancer stem cellsProc Natl Acad Sci U S A200710424101581016317548814
   PubMed Web of Science ®Google Scholar
• SchattonTMurphyGFFrankNYIdentification of cells initiating human melanomasNature2008451717634534918202660
   PubMed Web of Science ®Google Scholar
• QuintanaEShackletonMSabelMSFullenDRJohnsonTMMorrisonSJEfficient tumour formation by single human melanoma cellsNature2008456722259359819052619
   PubMed Web of Science ®Google Scholar
• McDermottSPWichaMSTargeting breast cancer stem cellsMol Oncol20104540441920599450
   PubMed Web of Science ®Google Scholar
• LiYLaterraJCancer stem cells: distinct entities or dynamically regulated phenotypes?Cancer Res201272357658022298594
   PubMed Web of Science ®Google Scholar
• TomasettiCVogelsteinBCancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisionsScience20153476217788125554788
   PubMed Web of Science ®Google Scholar
• ChafferCLBrueckmannIScheelCNormal and neoplastic nonstem cells can spontaneously convert to a stem-like stateProc Natl Acad Sci U S A2011108197950795521498687
   PubMed Web of Science ®Google Scholar
• EirewPStinglJRaoufAA method for quantifying normal human mammary epithelial stem cells with in vivo regenerative abilityNat Med200814121384138919029987
   PubMed Web of Science ®Google Scholar
• GinestierCHurMHCharafe-JauffretEALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell20071555556718371393
   PubMed Web of Science ®Google Scholar
• KarstenUGoletzSWhat makes cancer stem cell markers different?Springerplus20132130123888272
   PubMedGoogle Scholar
• ProiaTAKellerPJGuptaPBGenetic predisposition directs breast cancer phenotype by dictating progenitor cell fateCell Stem Cell20118214916321295272
   PubMed Web of Science ®Google Scholar
• LimEVaillantFWuDAberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriersNat Med200915890791319648928
   PubMed Web of Science ®Google Scholar
• MolyneuxGGeyerFCMagnayFABRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cellsCell Stem Cell20107340341720804975
   PubMed Web of Science ®Google Scholar
• CastanoZFillmoreCMKimCFMcAllisterSSThe bed and the bugs: interactions between the tumor microenvironment and cancer stem cellsSemin Cancer Biol2012225–646247022548722
   PubMed Web of Science ®Google Scholar
• ReyaTMorrisonSJClarkeMFWeissmanILStem cells, cancer, and cancer stem cellsNature2001414685910511111689955
   PubMed Web of Science ®Google Scholar
• ShackletonMQuintanaEFearonERMorrisonSJHeterogeneity in cancer: cancer stem cells versus clonal evolutionCell2009138582282919737509
   PubMed Web of Science ®Google Scholar
• TangDGUnderstanding cancer stem cell heterogeneity and plasticityCell Res201222345747222357481
   PubMed Web of Science ®Google Scholar
• DickJELooking ahead in cancer stem cell researchNat Biotechnol2009271444619131997
   PubMed Web of Science ®Google Scholar
• NowellPCThe clonal evolution of tumor cell populationsScience197619442602328959840
   PubMed Web of Science ®Google Scholar
• CampbellLLPolyakKBreast tumor heterogeneity: cancer stem cells or clonal evolution?Cell Cycle20076192332233817786053
   PubMed Web of Science ®Google Scholar
• GreavesMMaleyCCClonal evolution in cancerNature2012481738130631322258609
   PubMed Web of Science ®Google Scholar
• VermeulenLde Sousa e MeloFRichelDJMedemaJPThe developing cancer stem-cell model: clinical challenges and opportunitiesLancet Oncol2012132e83e8922300863
   PubMed Web of Science ®Google Scholar
• ManiSAGuoWLiaoMJThe epithelial-mesenchymal transition generates cells with properties of stem cellsCell2008133470471518485877
   PubMed Web of Science ®Google Scholar
• ScheelCEatonENLiSHParacrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breastCell2011145692694021663795
   PubMed Web of Science ®Google Scholar
• OwensTWNaylorMJBreast cancer stem cellsFront Physiol2013422523986719
   PubMed Web of Science ®Google Scholar
• BorovskiTDe SousaEMFVermeulenLMedemaJPCancer stem cell niche: the place to beCancer Res201171363463921266356
   PubMed Web of Science ®Google Scholar
• MeadsMBGatenbyRADaltonWSEnvironment-mediated drug resistance: a major contributor to minimal residual diseaseNat Rev Cancer20099966567419693095
   PubMed Web of Science ®Google Scholar
• DeNardoDGBrennanDJRexhepajELeukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyCancer Discov201111546722039576
   PubMed Web of Science ®Google Scholar
• SampieriKFoddeRCancer stem cells and metastasisSemin Cancer Biol201222318719322774232
   PubMed Web of Science ®Google Scholar
• TheodoropoulosPAPolioudakiHAgelakiSCirculating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancerCancer Lett201028819910619619935
   PubMed Web of Science ®Google Scholar
• BaccelliISchneeweissARiethdorfSIdentification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assayNat Biotechnol201331653954423609047
   PubMed Web of Science ®Google Scholar
• GiordanoAGaoHAnfossiSEpithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancerMol Cancer Ther201211112526253422973057
   PubMed Web of Science ®Google Scholar
• AktasBTewesMFehmTHauchSKimmigRKasimir-BauerSStem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patientsBreast Cancer Res2009114R4619589136
   PubMed Web of Science ®Google Scholar
• RaimondiCGradiloneANasoGEpithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patientsBreast Cancer Res Treat2011130244945521298334
   PubMed Web of Science ®Google Scholar
• MegoMGaoHLeeBNPrognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantationJ Cancer2012336938023074378
   PubMed Web of Science ®Google Scholar
• BalicMLinHYoungLMost early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotypeClin Cancer Res200612195615562117020963
   PubMed Web of Science ®Google Scholar
• LiuHGChenCYangHPanYFZhangXHCancer stem cell subsets and their relationshipsJ Transl Med201195021542915
   PubMed Web of Science ®Google Scholar
• ChiotakiRPolioudakiHTheodoropoulosPACancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectivesCurr Cancer Drug Targets201515325626925669721
   PubMed Web of Science ®Google Scholar
• FernandezSVBinghamCFittipaldiPTP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patientsBreast Cancer Res201416544525307991
   PubMed Web of Science ®Google Scholar
• FehmTBeckerSDuerr-StoerzerSDetermination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 statusBreast Cancer Res200795R7417963511
   PubMed Web of Science ®Google Scholar
• LiXLewisMTHuangJIntrinsic resistance of tumorigenic breast cancer cells to chemotherapyJ Natl Cancer Inst2008100967267918445819
   PubMedGoogle Scholar
• ChenKHuangYHChenJLUnderstanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacol Sin201334673274023685952
   PubMed Web of Science ®Google Scholar
• AbdullahLNChowEKMechanisms of chemoresistance in cancer stem cellsClin Transl Med201321323369605
   PubMedGoogle Scholar
• MadjdZMehrjerdiAZSharifiAMMolanaeiSShahzadiSZAsadi-LariMCD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumoursCancer Immun20099419385591
   PubMedGoogle Scholar
• KleffelSSchattonTTumor dormancy and cancer stem cells: Two sides of the same coin?Adv Exp Med Biol201373414517923143979
   PubMed Web of Science ®Google Scholar
• ShachafCMKopelmanAMArvanitisCMYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature200443170121112111715475948
   PubMed Web of Science ®Google Scholar
• SchoberMFuchsETumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin/focal adhesion kinase (FAK) signalingProc Natl Acad Sci U S A201110826105441054921670270
   PubMed Web of Science ®Google Scholar
• TobarNVillarVSantibanezJFROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasionMol Cell Biochem20103401–219520220204677
   PubMed Web of Science ®Google Scholar
• ThieryJPSleemanJPComplex networks orchestrate epithelial-mesenchymal transitionsNat Rev Mol Cell Biol20067213114216493418
   PubMed Web of Science ®Google Scholar
• NietoMAEpithelial plasticity: a common theme in embryonic and cancer cellsScience20133426159123485024202173
   PubMed Web of Science ®Google Scholar
• SinghRMoYYRole of microRNAs in breast cancerCancer Biol Ther201314320121223291983
   PubMed Web of Science ®Google Scholar
• JovanovicJRonnebergJATostJKristensenVThe epigenetics of breast cancerMol Oncol20104324225420627830
   PubMed Web of Science ®Google Scholar
• ThieryJPAcloqueHHuangRYNietoMAEpithelial-mesenchymal transitions in development and diseaseCell2009139587189019945376
   PubMed Web of Science ®Google Scholar
• YangJWeinbergRAEpithelial-mesenchymal transition: at the crossroads of development and tumor metastasisDev Cell200814681882918539112
   PubMed Web of Science ®Google Scholar
• AnsieauSEMT in breast cancer stem cell generationCancer Lett20133381636822634497
   PubMed Web of Science ®Google Scholar
• DrasinDJRobinTPFordHLBreast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityBreast Cancer Res201113622622078097
   PubMed Web of Science ®Google Scholar
• DaveBMittalVTanNMChangJCEpithelial-mesenchymal transition, cancer stem cells and treatment resistanceBreast Cancer Res201214120222264257
   PubMed Web of Science ®Google Scholar
• MorelAPLievreMThomasCHinkalGAnsieauSPuisieuxAGeneration of breast cancer stem cells through epithelial-mesenchymal transitionPloS One200838e288818682804
   PubMed Web of Science ®Google Scholar
• VoonDCWangHKooJKRunx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicityStem Cells201230102088209922899304
   PubMed Web of Science ®Google Scholar
• SarrioDRodriguez-PinillaSMHardissonDCanoAMoreno-BuenoGPalaciosJEpithelial-mesenchymal transition in breast cancer relates to the basal-like phenotypeCancer Res200868498999718281472
   PubMed Web of Science ®Google Scholar
• ManiSAYangJBrooksMMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersProc Natl Acad Sci U S A200710424100691007417537911
   PubMed Web of Science ®Google Scholar
• MizunoHSpikeBTWahlGMLevineAJInactivation of p53 in breast cancers correlates with stem cell transcriptional signaturesProc Natl Acad Sci U S A201010752227452275021149740
   PubMed Web of Science ®Google Scholar
• LiuJLiaoSDiop-FrimpongBTGF-beta blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stromaProc Natl Acad Sci U S A201210941166181662322996328
   PubMed Web of Science ®Google Scholar
• PeceSTosoniDConfalonieriSBiological and molecular heterogeneity of breast cancers correlates with their cancer stem cell contentCell20101401627320074520
   PubMed Web of Science ®Google Scholar
• McCubreyJADavisNMAbramsSLTargeting breast cancer initiating cells: advances in breast cancer research and therapyAdv Biol Regul2014568110724913694
   PubMedGoogle Scholar
• VieiraAFRicardoSAblettMPP-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancerStem Cells201230585486422389315
   PubMed Web of Science ®Google Scholar
• RibeiroASParedesJP-Cadherin linking breast cancer stem cells and invasion: A promising marker to identify an “intermediate/metastable” EMT stateFront Oncol2014437125601904
   PubMed Web of Science ®Google Scholar
• PolioudakiHAgelakiSChiotakiRVariable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancerBMC Cancer20151539925962645
   PubMed Web of Science ®Google Scholar
• PapadakiMAKallergiGZafeiriouZCo-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancerBMC Cancer20141465125182808
   PubMed Web of Science ®Google Scholar
• BockCRackBHuoberJAndergassenUJeschkeUDoisneau-SixouSDistinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patientsFuture Oncol201410101751176525303055
   PubMed Web of Science ®Google Scholar
• BarriereGRiouallonARenaudieJTartaryMRigaudMMesenchymal and stemness circulating tumor cells in early breast cancer diagnosisBMC Cancer20121211422443102
   PubMed Web of Science ®Google Scholar
• KrawczykNMeier-StiegenFBanysMNeubauerHRuckhaeberleEFehmTExpression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsBio Med Res Int20142014415721
   Google Scholar
• LecciaFDel VecchioLMariottiEABCG2, a novel antigen to sort luminal progenitors of BRCA1-breast cancer cellsMol Cancer20141321325216750
   PubMed Web of Science ®Google Scholar
• Fernandez-ZapicoMEGLI1 finds a new role in cancer stem cell biologyEMBO Mol Med20135448348523505092
   PubMed Web of Science ®Google Scholar
• LianidouESMarkouACirculating tumor cells in breast cancer: detection systems, molecular characterization, and future challengesClin Chem20115791242125521784769
   PubMed Web of Science ®Google Scholar
• BrockGCastellanos-RizaldosEHuLCottichiaCSkogJLiquid biopsy for cancer screening, patient stratification and monitoringTransl Cancer Res201543280290
   Web of Science ®Google Scholar
• Paterlini-BrechotPBenaliNLCirculating tumor cells (CTC) detection: clinical impact and future directionsCancer Lett2007253218020417314005
   PubMed Web of Science ®Google Scholar
• NagaiahGAbrahamJCirculating tumor cells in the management of breast cancerClin Breast Cancer201010320921620497919
   PubMed Web of Science ®Google Scholar
• Alunni-FabbroniMSandriMTCirculating tumour cells in clinical practice: Methods of detection and possible characterizationMethods201050428929720116432
   PubMed Web of Science ®Google Scholar
• HongBZuYDetecting circulating tumor cells: current challenges and new trendsTheranostics20133637739423781285
   PubMed Web of Science ®Google Scholar
• RiethdorfSFritscheHMullerVDetection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch systemClin Cancer Res200713392092817289886
   PubMed Web of Science ®Google Scholar
• StottSLHsuCHTsukrovDIIsolation of circulating tumor cells using a microvortex-generating herringbone-chipProc Natl Acad Sci U S A201010743183921839720930119
   PubMed Web of Science ®Google Scholar
• FehmTHoffmannOAktasBDetection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cellsBreast Cancer Res2009114R5919664291
   PubMed Web of Science ®Google Scholar
• DanilaDCPantelKFleisherMScherHICirculating tumors cells as biomarkers: progress toward biomarker qualificationCancer J201117643845022157288
   PubMed Web of Science ®Google Scholar
• ReubenJMLeeBNGaoHPrimary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44(+)CD24lo cancer stem cell phenotypeEur J Cancer201147101527153621334874
   PubMed Web of Science ®Google Scholar
• Nora DicksonMTsinbergPTangZBischoffFZWilsonTLeonardEFEfficient capture of circulating tumor cells with a novel immunocytochemical microfluidic deviceBiomicrofluidics20115334119341191522662044
   PubMed Web of Science ®Google Scholar
• Saucedo-ZeniNMewesSNiestrojRA novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wireInt J Oncol20124141241125022825490
   PubMed Web of Science ®Google Scholar
• BalicMDandachiNLinHDatarRHCancer metastasis: advances in the detection and characterization of disseminated tumour cells facilitate clinical translationNatl Med J India200518525025516433139
   PubMed Web of Science ®Google Scholar
• SatelliABrownleeZMitraAMengQHLiSCirculating tumor cell enumeration with a combination of epithelial cell adhesion moleculeand cell-surface vimentin-based methods for monitoring breast cancer therapeutic responseClin Chem201561125926625336717
   PubMed Web of Science ®Google Scholar
• Alix-PanabieresCEPISPOT assay: detection of viable DTCs/CTCs in solid tumor patientsRecent Results Cancer Res2012195697622527495
   PubMedGoogle Scholar
• OzkumurEShahAMCicilianoJCInertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cellsSci Transl Med20135179179ra147
   Web of Science ®Google Scholar
• KarabacakNMSpuhlerPSFachinFMicrofluidic, marker-free isolation of circulating tumor cells from blood samplesNat Protoc20149369471024577360
   PubMed Web of Science ®Google Scholar
• VonaGSabileALouhaMIsolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cellsAm J Pathol20001561576310623654
   PubMed Web of Science ®Google Scholar
• FaraceFMassardCVimondNA direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomasBr J Cancer2011105684785321829190
   PubMed Web of Science ®Google Scholar
• HardtOWildSOerleckeIHighly sensitive profiling of CD44+/CD24− breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathwayCancer Lett2012325216517422771536
   PubMed Web of Science ®Google Scholar
• PhucPVKhuongTTTDongLVTruongKDTranGPhanNKIsolation and characterization of breast cancer stem cells from malignant tumours in Vietnamese womenJCAB2010412163169
   Google Scholar
• LiuSCongYWangDBreast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsStem Cell Reports201421789124511467
   PubMed Web of Science ®Google Scholar
• Leth-LarsenRTerpMGChristensenAGFunctional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasisMol Med2012181109112122692575
   PubMed Web of Science ®Google Scholar
• MeyerMJFlemingJMLinAFHussnainSAGinsburgEVonderhaarBKCD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancerCancer Res201070114624463320484027
   PubMed Web of Science ®Google Scholar
• ZhangLRidgwayLDWetzelMDThe identification and characterization of breast cancer CTCs competent for brain metastasisSci Transl Med20135180180ra148
   Web of Science ®Google Scholar
• D’AmicoLPataneSGrangeCPrimary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signatureBr J Cancer2013108122525253623801032
   PubMed Web of Science ®Google Scholar
• WillinghamSBVolkmerJPGentlesAJThe CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProc Natl Acad Sci U S A2012109176662666722451913
   PubMed Web of Science ®Google Scholar
• MajetiRChaoMPAlizadehAACD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cellsCell2009138228629919632179
   PubMed Web of Science ®Google Scholar
• ChaoMPAlizadehAATangCTherapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemiaCancer Res20117141374138421177380
   PubMed Web of Science ®Google Scholar
• TrusolinoLBertottiAComoglioPMMET signalling: principles and functions in development, organ regeneration and cancerNat Rev Mol Cell Biol2010111283484821102609
   PubMed Web of Science ®Google Scholar
• CreightonCJLiXLandisMResidual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProc Natl Acad Sci U S A200910633138201382519666588
   PubMed Web of Science ®Google Scholar
• GenerPGouveiaLPSabatGRFluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cellsNanomedicine20151181883189226238079
   PubMed Web of Science ®Google Scholar
• SchottAFLandisMDDontuGPreclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumorsClin Cancer Res20131961512152423340294
   PubMed Web of Science ®Google Scholar
• LambROzsvariBLisantiCLAntibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious diseaseOncotarget2015674569458425625193
   PubMed Web of Science ®Google Scholar
• LambRFiorilloMChadwickADoxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapyOncotarget2015616140051402526087309
   PubMed Web of Science ®Google Scholar
• ChangMYOhBRheeYHLeeSHDoxycycline supplementation allows for the culture of human ESCs/iPSCs with media changes at 3-day intervalsStem Cell Res201515360861326513556
   PubMed Web of Science ®Google Scholar
• ChangMYRheeYHYiSHDoxycycline enhances survival and self-renewal of human pluripotent stem cellsStem Cell Reports20143235336425254347
   PubMed Web of Science ®Google Scholar
• GuptaPBOnderTTJiangGIdentification of selective inhibitors of cancer stem cells by high-throughput screeningCell2009138464565919682730
   PubMed Web of Science ®Google Scholar
• KimYJLiuYLiSCo-eradication of breast cancer cells and cancer stem cells by cross-linked multilamellar liposomes enhances tumor treatmentMol Pharm20151282811282226098197
   PubMed Web of Science ®Google Scholar
• YuMBardiaAAcetoNCancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityScience2014345619321622025013076
   PubMed Web of Science ®Google Scholar
• MominENVelaGZaidiHAQuinones-HinojosaAThe oncogenic potential of mesenchymal stem cells in the treatment of cancer: directions for future researchCurr Immunol Rev20106213714820490366
   PubMedGoogle Scholar
• ShahKMesenchymal stem cells engineered for cancer therapyAdv Drug Deliv Rev201264873974821740940
   PubMed Web of Science ®Google Scholar
• QiaoLXuZZhaoTSuppression of tumorigenesis by human mesenchymal stem cells in a hepatoma modelCell Res200818450050718364678
   PubMed Web of Science ®Google Scholar
• OhtaNIshiguroSKawabataAHuman umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genesPloS One2015105e012375625942583
   PubMed Web of Science ®Google Scholar
• ChaoKCYangHTChenMWHuman umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalizationJ Cell Mol Med20121681803181521973190
   PubMed Web of Science ®Google Scholar
• MaYHaoXZhangSZhangJThe in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cellsBreast Cancer Res Treat2012133247348521947651
   PubMed Web of Science ®Google Scholar
• IllouzYGBreast cancer treatment by adipose-derived stem cells: an experimental studyJ Stem Cells20149421121725942336
   PubMedGoogle Scholar
• BertoliniFPetitJYKoloninMGStem cells from adipose tissue and breast cancer: hype, risks and hopeBr J Cancer2015112341942325584493
   PubMed Web of Science ®Google Scholar
• RowanBGGimbleJMShengMHuman adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenograftsPloS One201492e8959524586900
   PubMed Web of Science ®Google Scholar
• OrecchioniSGregatoGMartin-PaduraIComplementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancerCancer Res201373195880589123918796
   PubMed Web of Science ®Google Scholar
• KangNHHwangKAYiBRHuman amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse modelsCancer Gene Ther201219641241922498724
   PubMed Web of Science ®Google Scholar
• KangNHYiBRLimSYHuman amniotic membrane-derived epithelial stem cells display anticancer activity in BALB/c female nude mice bearing disseminated breast cancer xenograftsInt J Oncol20124062022202822344679
   PubMed Web of Science ®Google Scholar
• Bagci-OnderTDuWFigueiredoJLMartinez-QuintanillaJShahKTargeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cellsBrain2015138Pt 61710172125910782
   PubMed Web of Science ®Google Scholar
• KanojiaDBalyasnikovaIVMorshedRANeural stem cells secreting anti-HER2 antibody improve survival in a preclinical model of HER2 overexpressing breast cancer brain metastasesStem Cells201533102985299426260958
   PubMed Web of Science ®Google Scholar
• SeolHJJinJSeongDHGenetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancerCancer Lett2011311215215921868150
   PubMed Web of Science ®Google Scholar
• YiBRHwangKAAboodyKSJeungEBKimSUChoiKCSelective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft modelsStem Cell Res2014121364824141111
   PubMed Web of Science ®Google Scholar
• HallBDembinskiJSasserAKStudenyMAndreeffMMariniFMesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehiclesInt J Hematol200786181617675260
   PubMed Web of Science ®Google Scholar
• KarnoubAEDashABVoAPMesenchymal stem cells within tumour stroma promote breast cancer metastasisNature2007449716255756317914389
   PubMed Web of Science ®Google Scholar